Evidence map›Paper›PMID 31515273›Full record

ArticleThe Journal of biological chemistry2019

Structural and mechanistic insights into the interaction of the circadian transcription factor BMAL1 with the KIX domain of the CREB-binding protein.

Archit Garg, Roberto Orru, Weixiang Ye, Ute Distler, Jeremy E Chojnacki, Maja Köhn, Stefan Tenzer, Carsten Sönnichsen, Eva Wolf

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. The CLOCK-BMAL1 complex in circadian regulation: structure, mechanisms, and therapeutic targeting.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  2. CBP/p300, a promising therapeutic target for prostate cancer.Journal of translational medicine · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Interactions by Disorder - A Matter of Context.Frontiers in molecular biosciences · 2020
    Review
  8. Circadian Regulation of Immunity Through Epigenetic Mechanisms.Frontiers in cellular and infection microbiology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Archit GargInstitute of Molecular Biology (IMB), Ackermannweg 4, 55128 Mainz, Germany.
Roberto OrruInstitute of Molecular Physiology, Johannes Gutenberg-University of Mainz, 55128 Mainz, Germany.
Weixiang YeInstitute of Physical Chemistry, Johannes Gutenberg-University of Mainz, Duesbergweg 10-14, 55128 Mainz, Germany.
Ute DistlerInstitute of Immunology, University Medical Center of the Johannes-Gutenberg University Mainz, 55131 Mainz, Germany.ORCID 0000-0002-8031-6384
Jeremy E ChojnackiEuropean Molecular Biology Laboratory, 69117 Heidelberg, Germany.
Maja KöhnEuropean Molecular Biology Laboratory, 69117 Heidelberg, Germany.ORCID 0000-0001-8142-3504
Stefan TenzerInstitute of Immunology, University Medical Center of the Johannes-Gutenberg University Mainz, 55131 Mainz, Germany.ORCID 0000-0003-3034-0017
Carsten SönnichsenInstitute of Physical Chemistry, Johannes Gutenberg-University of Mainz, Duesbergweg 10-14, 55128 Mainz, Germany.
Eva WolfInstitute of Molecular Biology (IMB), Ackermannweg 4, 55128 Mainz, Germany evawolf1@uni-mainz.de.ORCID 0000-0003-1345-6114
Johannes Gutenberg University Mainz · DEEuropean Molecular Biology Laboratory · DEInstitute of Molecular Biology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mammalian CLOCK:BMAL1 transcription factor complex and its coactivators CREB-binding protein (CBP)/p300 and mixed-lineage leukemia 1 (MLL1) critically regulate circadian transcription and chromatin modification. Circadian oscillations are regulated by interactions of BMAL1's C-terminal transactivation domain (TAD) with the KIX domain of CBP/p300 (activating) and with the clock protein CRY1 (repressing) as well as by the BMAL1 G-region preceding the TAD. Circadian acetylation of Lys

Indexed as

Circadian ClocksAmino Acid SequenceAnimalsARNTL Transcription FactorsBinding SitesCREB-Binding ProteinHistone-Lysine N-MethyltransferaseMiceMutagenesis, Site-DirectedMyeloid-Lymphoid Leukemia ProteinProtein BindingProtein DomainsProtein Structure, SecondaryProtein Structure, TertiaryProto-Oncogene Proteins c-mybRecombinant ProteinsARNTL Transcription FactorsCREB-Binding ProteinHistone-Lysine N-MethyltransferaseKmt2a protein, mouseMyeloid-Lymphoid Leukemia ProteinProto-Oncogene Proteins c-mybRecombinant ProteinsbiophysicsBMAL1 G-regionbrain and muscle ARNT-like protein-1 (BMAL1)chromatin modificationcircadian clockcircadian gene regulationCREB-binding protein (CBP)gene regulationkinase inducible domain interacting (KIX) domain of CBPprotein interactionsSAXSstructural biologytransactivation domain (TAD)transcriptional rhythmicitytranscription regulation

Identifiers

PMID31515273
PMCPMC6851309
OpenAlexW2972784310

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.